Minhong Yan

Years Active: 2020-2022
Publications (10 Years): 4

This page only lists publications with an associated author ORCID identifier.

Publications

Vivekananda Kedage, Diego Ellerman, Mingjian Fei, Wei-Ching Liang, Gu Zhang, Eric Cheng, Juan Zhang, Yongmei Chen, Haochu Huang, Wyne P Lee, Yan Wu, Minhong Yan
CLEC5a-directed bispecific antibody for effective cellular phagocytosis. mAbs 14 (1) (2022)
Yvonne Chen, Maciej Paluch, Julie A Zorn, Sharmila Rajan, Brandon Leonard, Alberto Estevez, John Brady, Henry Chiu, Wilson Phung, Amin Famili, Minhong Yan, Claudio Ciferri, Marissa L Matsumoto, Greg A Lazar, Susan Crowell, Phil Hass, Nicholas J Agard
Targeted IgMs agonize ocular targets with extended vitreal exposure. mAbs 12 (1) (2021)
Vivekananda Kedage, Diego Ellerman, Yongmei Chen, Wei-Ching Liang, Joven Borneo, Yan Wu, Minhong Yan
Harnessing MerTK agonism for targeted therapeutics. mAbs 12 (1) (2021)
Soyoung A Oh, Dai-Chen Wu, Jeanne Cheung, Armando Navarro, Huizhong Xiong, Rafael Cubas, Klara Totpal, Henry Chiu, Yan Wu, Laetitia Comps-Agrar, Andrew M Leader, Miriam Merad, Merone Roose-Germa, Soren Warming, Minhong Yan, Jeong M Kim, Sascha Rutz, Ira Mellman
PD-L1 expression by dendritic cells is a key regulator of T-cell immunity in cancer. Nature cancer 1 (7) (2020)

Minhong Yan.css-eqlu8i{font-size:small;padding-left:4px;}